197 related articles for article (PubMed ID: 29879025)
1. Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma.
Shang YK; Li F; Zhang Y; Liu ZK; Wang ZL; Bian H; Chen ZN
Medicine (Baltimore); 2018 Jun; 97(23):e10892. PubMed ID: 29879025
[TBL] [Abstract][Full Text] [Related]
2. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation Profiling of Human Hepatocarcinogenesis.
Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
[TBL] [Abstract][Full Text] [Related]
4. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma.
Jiang CH; Yuan X; Li JF; Xie YF; Zhang AZ; Wang XL; Yang L; Liu CX; Liang WH; Pang LJ; Zou H; Cui XB; Shen XH; Qi Y; Jiang JF; Gu WY; Li F; Hu JM
J Transl Med; 2020 Jan; 18(1):40. PubMed ID: 32000807
[TBL] [Abstract][Full Text] [Related]
6. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
8. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
9. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
[TBL] [Abstract][Full Text] [Related]
11. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
[TBL] [Abstract][Full Text] [Related]
13. FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection.
Li F; Liu T; Xiao CY; Yu JX; Lu LG; Xu MY
Biomed Pharmacother; 2015 May; 72():103-8. PubMed ID: 26054682
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma.
Shangguan H; Tan SY; Zhang JR
Eur Rev Med Pharmacol Sci; 2015; 19(11):2054-61. PubMed ID: 26125269
[TBL] [Abstract][Full Text] [Related]
15. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
16. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma.
Liu XF; Thin KZ; Ming XL; Shuo-Li ; Ping-Luo ; Man-Zhu ; Li ND; Tu JC
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794494. PubMed ID: 30126319
[TBL] [Abstract][Full Text] [Related]
17. Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy.
Dolicka D; Sobolewski C; Gjorgjieva M; Correia de Sousa M; Berthou F; De Vito C; Colin DJ; Bejuy O; Fournier M; Maeder C; Blackshear PJ; Rubbia-Brandt L; Foti M
Cell Mol Gastroenterol Hepatol; 2021; 11(2):597-621. PubMed ID: 32987153
[TBL] [Abstract][Full Text] [Related]
18. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
[TBL] [Abstract][Full Text] [Related]
19. The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Ye G; Qin Y; Lu X; Xu X; Xu S; Wu C; Wang X; Wang S; Pan D
Biochem Biophys Res Commun; 2015 Mar; 459(1):18-23. PubMed ID: 25701390
[TBL] [Abstract][Full Text] [Related]
20. Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background.
Motalebzadeh J; Eskandari E
Med Oncol; 2021 Sep; 38(10):121. PubMed ID: 34468893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
